Literature DB >> 11860364

The cell biology of parasitism in Trypanosoma brucei: insights and drug targets from genomic approaches?

K Gull1.   

Abstract

The African trypanosome, Trypanosoma brucei exhibits a complex, digenetic life cycle that alternates between the tsetse fly vector and the mammalian host. The life cycle is characterised by a complex series of cell type differentiations and variations in metabolism. In addition the trypanosome exhibits a particular cell biology that has become adapted for its role as a parasite. This article places some of these areas in a frame-work that considers the role of cellular processes in parasitism. I rehearse some conclusions from recent studies and provide hyphotheses and suggestions for future work. Areas debated include: cell surface protein expression, cell differentiation, endomembrane trafficking and protein targeting, the cytoskeleton,flagellum functions in motility, attachment and plasma membrane differentiation, organelle specialisations, control of cell cycle, parasite/host, parasite/parasite and parasite/vector interactions. The review also focuses on the likely impact of the genome project and reverse genetics in providing greater insight to these cellular processes and how, if coordinated with some alan by scientists and funding agencies, this may provide novel targets for future drug development.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11860364     DOI: 10.2174/1381612023396212

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  9 in total

1.  Target repurposing for neglected diseases.

Authors:  Michael P Pollastri; Robert K Campbell
Journal:  Future Med Chem       Date:  2011-08       Impact factor: 3.808

2.  The role of vascular endothelium and exosomes in human protozoan parasitic diseases.

Authors:  Sanjay Varikuti; Bijay Kumar Jha; Erin A Holcomb; Jodi C McDaniel; Manjula Karpurapu; Nidhi Srivastava; Bradford S McGwire; Abhay R Satoskar; Narasimham L Parinandi
Journal:  Vessel Plus       Date:  2020-09-27

3.  Immunization with recombinant actin from Trypanosoma evansi induces protective immunity against T. evansi, T. equiperdum and T. b. brucei infection.

Authors:  San-Qiang Li; Wu-Biao Yang; Zhao-Rong Lun; Ling-Jun Ma; Shou-Min Xi; Qun-Li Chen; Xiao-Wei Song; Jian Kang; Lan-Ze Yang
Journal:  Parasitol Res       Date:  2008-10-16       Impact factor: 2.289

4.  Evaluation of Triazole and Isoxazole Derivatives as Potential Anti-infective Agents.

Authors:  Amer H Tarawneh; Lo Ay A Al-Momani; Francisco León; Surenda K Jain; Anastassiya V Gadetskaya; Sultan T Abu-Orabi; Babu L Tekwani; Stephen J Cutler
Journal:  Med Chem Res       Date:  2018-02-27       Impact factor: 1.965

5.  Identification of selective tubulin inhibitors as potential anti-trypanosomal agents.

Authors:  Rati Lama; Ranjodh Sandhu; Bo Zhong; Bibo Li; Bin Su
Journal:  Bioorg Med Chem Lett       Date:  2012-07-14       Impact factor: 2.823

6.  CRK9 contributes to regulation of mitosis and cytokinesis in the procyclic form of Trypanosoma brucei.

Authors:  Stephane Gourguechon; Ching C Wang
Journal:  BMC Cell Biol       Date:  2009-09-21       Impact factor: 4.241

7.  From the cell biology to the development of new chemotherapeutic approaches against trypanosomatids: dreams and reality.

Authors:  Wanderley De Souza
Journal:  Kinetoplastid Biol Dis       Date:  2002-05-31

Review 8.  The Trypanosome Flagellar Pocket Collar and Its Ring Forming Protein-TbBILBO1.

Authors:  Doranda Perdomo; Mélanie Bonhivers; Derrick R Robinson
Journal:  Cells       Date:  2016-03-02       Impact factor: 6.600

9.  Orally Active and Selective Tubulin Inhibitors as Anti-Trypanosome Agents.

Authors:  Vishal Nanavaty; Rati Lama; Ranjodh Sandhu; Bo Zhong; Daniel Kulman; Viharika Bobba; Anran Zhao; Bibo Li; Bin Su
Journal:  PLoS One       Date:  2016-01-15       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.